期刊文献+

脑钠肽与小儿心血管疾病 被引量:2

Brain Natriuretic Peptide and Cardiovascular Disease in Children
下载PDF
导出
摘要 脑钠肽(BNP)主要由心室分泌,血浆浓度与心室体积或压力负荷程度呈正比。具有很强的排钠、利尿、扩张血管、抑制肾素-血管紧张素-醛固酮系统(RAAS)和交感神经系统活性作用,有助于充血性心力衰竭的诊断、疗效监测、预后评估和治疗。该文就BNP的生物学特性、检测方法及其在儿童心血管疾病中的临床应用简要综述。 Brain natriuretic peptide (BNP) is mainly secreted from the cardiac ventricles and its plasma concentration is positive correlated with the pressure or volume overload of ventricular It has strong action of natriuresis, diuresis, vasodilation, inhibition of rennin-angiotensin-aldosterone system and sympathic nervous system. The detection of BNP may be helpful to the diagnosis, efficacy monitoring, prognosis evaluation and therapy of congestive heart failure. This article simply reviews the BNP about its biology character, detection method and its application in children with cardiovascular diseades.
作者 陈静 张宏艳
出处 《医学综述》 2006年第9期526-529,共4页 Medical Recapitulate
关键词 心力衰竭 脑钠肽 诊断 治疗 Congestive heart failure Brain natriuretic peptide Diagnosis Treatment
  • 相关文献

参考文献18

  • 1Sudoh T,Kangawa K,Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988,332(6159) :78-81.
  • 2Hammerer-Lercher A, Neubauer E, Muller S, et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial antriuretic peptide in diagnosing left ventricular dysfunction[J]. Clin Chim Acta,2001,310(2) : 193-197.
  • 3Cea LB. Natriuretic peptide family : new aspects[J]. Curr Med Chem Cardiovasc Hematol Agents,2005,3(2) :87-98.
  • 4Jourdain P, Funck F, Bellorini M, et al. Bedside B-type natriuretic peptide and functional capacity in chronic heart failure[J]. Eur J Heart Fail,2003,5(2) :155-160.
  • 5Koulouri S, Acherman RJ, Wong PC, et al, Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress[J]. Pediatr Cardiol,2004,25(4) :341-346.
  • 6Maisel AS, Koon J, Krishnaswarny P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J]. Am Heart J,2001,141(3) :367-374.
  • 7Mir TS, Marohn S, Laer S, et al. Plasma concentrations of N-Terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure[J]. Pediatrics,2002,110(6) :e76.
  • 8Hayakawa H, Komada Y, Hirayama M, et al. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer[J]. Med Pediatr Oncol,2001,37( 1 ) :4-9.
  • 9Suzuki T, Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels[J] .Jpn Heart J,2000,41(2) :205-214.
  • 10Tsutamoto T, Wada A. Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction[J].Circulation, 1997,96(2) :509-516.

同被引文献1632

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部